EPISODE · Feb 25, 2022 · 12 MIN
AAV-gene therapy in galactosemia patient fibroblasts
from JIMD Podcasts · host Journal of Inherited Metabolic Disease
Dr Megan Brophy and Dr Bob Bell join the podcast to talk about their recent work looking at AAV gene therapy in fibroblasts from patients with classic galactosemia. We discuss new insights into disease physiology and consider the challenges of scaling gene therapy towards in vivo model. AAV-mediated expression of galactose-1-phosphate uridyltransferase corrects defects of galactose metabolism in classic galactosemia patient fibroblasts Megan L. Brophy, et al https://doi.org/10.1002/jimd.12468
What this episode covers
Dr Megan Brophy and Dr Bob Bell join the podcast to talk about their recent work looking at AAV gene therapy in fibroblasts from patients with classic galactosemia. We discuss new insights into disease physiology and consider the challenges of scaling gene therapy towards in vivo model. AAV-mediated expression of galactose-1-phosphate uridyltransferase corrects defects of galactose metabolism in classic galactosemia patient fibroblasts Megan L. Brophy, et al https://doi.org/10.1002/jimd.12468
NOW PLAYING
AAV-gene therapy in galactosemia patient fibroblasts
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m